Allogeneic Expanded Gamma Delta T Cells With GD2 Chemoimmunotherapy in Relapsed or Refractory Neuroblastoma

Conditions:   Neuroblastoma;   Refractory Neuroblastoma;   Relapsed Neuroblastoma Intervention:   Combination Product: Ex Vivo Expanded Allogeneic γδ T Cells in Combination with Dinutuximab, Temozolomide, Irinotecan and Zoledronate Sponsor:   Emory University Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials